Keywords:SB525334,supplier,Selective,inhibitors,inhibits,TGF-βRI,TGF-β,TGF-betaRI,TGFbRI,TGFbR1,tgf-b1Transforming,Growth,Factors,Beta,Receptors,TGF-beta,Receptor,Serine/Threonine,Kinases,RSTKs,SB525334,GlaxoSmithKline,GSK,TGF-beta,Receptors,TGF-beta,Receptors,TocrisBioscience